Proprietary Blends Hide What You Are Paying For

The practice, named plainly

A supplement proprietary blend is a label format that lets a company group several ingredients under one blend name, list the total weight of that blend, and avoid disclosing the dose of each ingredient inside it. The verdict: this is legal, but it is usually bad for consumers. It gives the brand more information than the buyer, and that gap matters most when a formula contains stimulants, botanicals, amino acids, sleep ingredients, or anything where the useful dose is narrow.¹

The charitable argument is that companies use proprietary blends to protect formulas from copycats. That argument is not imaginary. A 2023 review in Nutrients describes formula protection as a central rationale for proprietary blends, while also noting the practical problem for researchers and consumers: the label can obscure whether the amounts match doses used in studies.² In plain terms, a proprietary blend can protect intellectual property, but it can also protect underdosing from scrutiny.

What the rules actually allow

U.S. supplement labels are governed by FDA rules, including 21 CFR 101.36 for Supplement Facts panels. The rule allows dietary ingredients without Daily Values, often called other dietary ingredients, to appear inside a proprietary blend. The label must show the total quantitative amount of the blend and list the ingredients in descending order of predominance by weight.¹ That ordering helps a little. If caffeine appears before an herb, it weighs more than that herb. But the label still does not tell you whether an ingredient is present at 300 mg, 30 mg, or 3 mg.

The FDA also regulates dietary supplement manufacturing through current good manufacturing practice rules in 21 CFR Part 111. Those rules cover manufacturing, packaging, labeling, holding, specifications, records, and quality controls.⁶ They are not a premarket proof system for whether a blend works. FDA guidance also makes clear that dietary supplement firms are responsible for ensuring their products are properly labeled.³ In practice, the company decides to sell the product, and FDA enforcement generally happens after a compliance problem, inspection, adverse event signal, or market surveillance finding.

Third party programs fill part of that gap, but not all of it. USP says its Dietary Supplement Verification Program evaluates quality, purity, potency, performance, and consistency, and that a USP Verified product means what is on the label is in the bottle.⁴ NSF describes supplement certification as involving product testing and facility audits, including NSF/ANSI 173 for dietary supplements.⁵ Those programs can be meaningful quality signals. They do not turn a vague formula into a transparent one unless the product label itself discloses the individual active doses.

The public record shows why opacity matters

The proprietary blend problem is not the same as illegal adulteration. A product can use a proprietary blend and still be lawful. A product can also disclose every dose and still be poorly formulated. The critique is narrower: hidden doses make it harder to evaluate a product before you buy it.

That matters because supplement labels are not always reliable in higher risk categories. In a 2018 JAMA Network Open analysis of FDA warnings from 2007 through 2016, researchers identified 776 dietary supplements that contained unapproved pharmaceutical ingredients. These products were commonly marketed for sexual enhancement, weight loss, and muscle building.7 This was not a proprietary blend study, and it should not be used to claim that all blends are adulterated. It does show that the supplement market contains real enforcement problems, especially in categories that often use aggressive performance claims.

A separate 2023 JAMA Network Open case series tested 57 sports supplements labeled as containing certain botanical or performance enhancing ingredients. Forty percent contained no detectable amount of the labeled ingredient, and several contained FDA prohibited ingredients.⁸ Again, this does not prove that proprietary blends caused the problem. It does show why label opacity is not a harmless design choice. If a product will not disclose amounts, and the category already has documented label accuracy issues, the consumer has little basis for trust beyond brand reputation and third party verification.

FDA's own Health Fraud Product Database reinforces the same point from a regulatory angle. The database includes products cited in warning letters, recalls, public notifications, and press announcements for issues such as undeclared ingredients and disease related claims, and FDA notes that the list is only a small fraction of potentially hazardous products sold online and in stores.⁹ Hidden per ingredient dosing is not the worst conduct in that universe. It is the softer, legal opacity that makes the market harder to police from the consumer side.

What the evidence says about harm and benefit

The direct harm evidence on proprietary blends themselves is thin. There is no clean trial showing that the label format, by itself, injures consumers. The harm is mostly informational. You cannot compare the amount of creatine, beta alanine, ashwagandha, melatonin, magnesium, or caffeine against studied ranges if the label hides those amounts. You also cannot easily identify stacking risk when you take multiple products that contain overlapping ingredients.

The benefit evidence is also thin from the consumer perspective. Protecting a formula may benefit a company. It might encourage product development in some cases. But consumers are not buying trade secrets. They are buying effects, safety, and value. For ingredients with human studies, dose is not a technical detail. It is the difference between a plausible product and label decoration.

Practical guidance

Start with a simple screen: if an active ingredient is important enough to advertise, its amount should be disclosed. Prefer labels that list milligrams or micrograms for every active ingredient. Be more skeptical of blends in pre workouts, fat loss products, sexual enhancement products, sleep aids, and multi ingredient nootropic formulas, because these categories can combine stimulants, sedatives, or pharmacologically active botanicals.

Use the ingredient order only as a rough clue. Ingredients in a proprietary blend must be listed from most to least by weight, but that does not establish effective dosing.¹ A 1,000 mg blend with ten ingredients cannot contain 1,000 mg of each. If the first ingredient needs 3 grams in studies, the math already fails.

Look for credible third party certification, especially USP Verified, NSF Certified, or NSF Certified for Sport when athletic drug testing matters.⁴, ⁵ Treat certification as a quality filter, not a clinical dosing guarantee. A certified mystery dose is still a mystery dose.

The best buying rule is blunt: do not pay premium prices for hidden math. Proprietary blends are legal because the regulation permits them. They are popular because they help brands control information. A transparent label does not prove a supplement works, but it gives you the minimum data needed to decide whether it is worth taking.